Skip to main content
Log in

A Mathematical Model of Cell Cycle Effects in Gastric Cancer Chemotherapy

  • Original Article
  • Published:
Bulletin of Mathematical Biology Aims and scope Submit manuscript

Abstract

A mathematical model is presented to investigate the relationship between drug order and treatment response in gastric cancer chemotherapy involving a taxane (either paclitaxel or docetaxel) coupled with flavopiridol. To model treatment effects, we simulate treatment by bolus injection and employ a pulsing condition to indicate cell kill as well as instantaneous changes to the cell’s transition rates. Cell population growth is described using an ordinary differential equation model whereby we examine the treatment effects upon cells in various stages of the cell cycle. Ultimately, the results generated support prior clinical investigations which indicate that for an enhanced synergistic effect, flavopiridol must be administered following taxane therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bast, R. C., et al. (Eds.) (2005). Cancer medicine. New York: Decker.

    Google Scholar 

  • Ecker, J., & Kupferschmid, M. (2004). Introduction to operations research. Melbourne: Krieger.

    Google Scholar 

  • Edelstein-Keshet, L. (1988). Mathematical models in biology. New York: McGraw-Hill.

    MATH  Google Scholar 

  • Motwani, M., et al. (2003). Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. Mol. Cancer Ther., 2, 549–555.

    Google Scholar 

  • Motwani, M., Delohery, T., & Schwartz, G. (1999). Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin. Cancer Res., 5, 1876–1883.

    Google Scholar 

  • Panetta, J., & Adam, J. (1995). A mathematical model of cycle-specific chemotherapy. Math. Comput. Model., 22, 67–82.

    Article  MathSciNet  MATH  Google Scholar 

  • Roe-Dale, R., Isaacson, D., & Kupferschmid, M. (2010). A mathematical model of breast cancer treatment with CMF and doxorubicin. Bull. Math. Biol., 73, 585–608.

    Article  MathSciNet  Google Scholar 

  • Schwartz, G. et al. (2002). Phase I study of the cycle-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. J. Clin. Oncol., 20, 2157–2170.

    Article  Google Scholar 

  • Shah, M., & Schwartz, G. (2001). Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin. Cancer Res., 7, 2168–2181.

    Google Scholar 

  • Takahashi, M. (1966). Theoretical basis for cell cycle analysis I: labelled mitosis wave method. J. Theor. Biol., 13, 202–211.

    Article  Google Scholar 

  • Takahashi, M. (1968). Theoretical basis for cell cycle analysis II: further studies on labelled mitosis wave method. J. Theor. Biol., 18, 195–209.

    Article  Google Scholar 

  • Weldon, T. E. (1988). Mathematical models in cancer research. Bristol: Hilger.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachel Roe-Dale.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roe-Dale, R., Isaacson, D. & Kupferschmid, M. A Mathematical Model of Cell Cycle Effects in Gastric Cancer Chemotherapy. Bull Math Biol 74, 159–174 (2012). https://doi.org/10.1007/s11538-011-9669-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11538-011-9669-x

Keywords

Navigation